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Introduction
============

Globally, the burden of overweight and obesity has been increasing substantially affecting almost 30% of the entire world population \[[@REF1]\]. Overweight and obesity are defined as an excessive accumulation of body fat or weight that exceeds the age- and gender-specific reference limits leading to ill health and a high incidence of non-communicable diseases such as metabolic syndrome (MetS) \[[@REF1]-[@REF2]\]. Pakistan ranks ninth among the world\'s most obese nations \[[@REF1]\].

MetS is a serious health condition that can lead to several chronic, non-communicable diseases such as cardiovascular disease and diabetes mellitus \[[@REF3]\]. MetS is a combination of at least three of the following five metabolic abnormalities: 1) elevated waist circumference (cutoff for Asians: ≥90 cm/35.4 inches in men and ≥80 cm/31.5 inches in women), 2) elevated triglycerides (TG; ≥150 mg/dL), 3) reduced high-density lipoprotein (HDL; \<40 mg/dL in men and \<50 mg/dL in women), 4) elevated blood pressure (systolic blood pressure \[SBP\] ≥130 mmHg or diastolic blood pressure \[DBP\] ≥85 mm Hg) or hypertensive, and 5) elevated fasting blood glucose level (≥100 mg/dL or 5.6 mmol/L) or diabetic \[[@REF4]\].

There are several criteria for diagnosing MetS, of which the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) and the International Diabetes Federation (IDF) are the most widely used criteria in Pakistan due to their reliability \[[@REF5]-[@REF6]\]. According to these criteria, the prevalence of MetS in Pakistan over the last decade is reported to be 35% to 64% \[[@REF7]-[@REF8]\]. According to the report of the Global Burden of Disease (GBD), the disability-adjusted life years (DALYs) attributable to risk factors associated with the diagnosis of MetS have dramatically increased over the past two decades \[[@REF9]\]. The report revealed that in 2010, high BMI and diabetes ranked sixth among the various leading risk factors and non-communicable diseases contributing to DALYs \[[@REF9]\].

Waist circumference (WC) is commonly used to define central obesity and plays a vital role in diagnosing obesity and MetS. The measurement of WC may be significantly influenced by various measuring methods, weather conditions, particularly winter, and interday variations that might affect the abdominal wall and abdominal cavity \[[@REF10]\]. Literature has shown that the heterogeneity in body structure and abdominal tissues depend on not only age and gender but also ethnicity \[[@REF11]\]. Hence, the IDF has now proposed lower cut-off values for WC for some ethnicities \[[@REF11]\]. Moreover, BMI, which is considered as another valuable tool to assess overweight and obesity, does not evaluate fat distribution; hence, it cannot always assess the individual risk of endocrine and metabolic complications.

Therefore, several studies have been carried out to assess the alternative anthropometric measure for diagnosing overweight, obesity, and MetS. Recently, researchers have greatly focused on NC, a parameter of upper-body adiposity. NC is a simpler, relatively new and practical anthropometric indicator that is not affected by the postprandial abdominal distension or by respiratory movements and can be particularly useful in specific populations such as morbidly obese people, patients in bed rest, and pregnant women \[[@REF9]\].

NC has been shown to be promising in diagnosing overweight and obesity and is also significantly associated with cardiovascular disease, SBP and DBP, and TG, total cholesterol, and fasting blood sugar levels; NC is also a predictor of obstructive sleep apnea syndrome in the Framingham study \[[@REF7],[@REF12]-[@REF13]\].

Moreover, recent studies have also reported a significant and positive correlation between NC and MetS \[[@REF14]-[@REF15]\]. A study done in Pakistan in 2016 has reported a higher NC in the MetS group in comparison to the non-MetS group \[[@REF14]\]. Additionally, the study reported NC ≥38 cm and ≥34 cm as the optimal cutoff values for the diagnosis of MetS in males and females, respectively \[[@REF14]\]. However, a systematic review and meta-analysis done in 2018 reported significant positive associations between NC and the various factors of MetS but has reported no association between the two \[[@REF16]\].

We aimed to conduct this study to assess the prevalence of MetS owing to the dearth of local literature reporting the current burden of MetS in Pakistan. Also, this study intended to gauge the optimal cutoff values of NC provided by Hingorjo MR et al. \[[@REF17]\].

Materials and methods
=====================

This cross-sectional study was conducted at the Indus Hospital, Karachi (TIH), a free-of-cost tertiary care facility. A priori sample size was calculated using OpenEpi software (Open Source Epidemiologic Statistics for Public Health, Version 3.01) with the following assumptions: MetS prevalence of 49% and the desired precision of 5% \[[@REF7]\]. The required sample size was estimated to be 384. All patients of either gender and age ≥18 years presenting to the outpatient clinics or admitted in the medical unit with BMI \>23 kg/m^2^ as per the Asian criteria and had given informed consent were included in the study through non-probability consecutive sampling \[[@REF18]\].

Patients with clinical or laboratory evidence of cardiac failure (stage C and D), liver failure, hyper or hypothyroidism, known congenital syndromes that lead to obesity, or on systemic steroids were excluded from the study.

Data on socio-demographic characteristics, such as age, gender, comorbidities, anthropometric variables (height, weight, BMI, NC, WC), and blood pressure, were gathered. MetS screening tool used by the Department of Mental Health, Missouri was used to assess MetS \[[@REF17]\]. Recent biochemical profiles of individual patients such as fasting plasma glucose, TC, LDP, TG, and HDP levels were extracted from the Hospital Information Management System (HIMS) of TIH. All data were recorded on a pre-designed questionnaire.

Blood pressure was measured using the auscultatory method, which uses a mercury sphygmomanometer and stethoscope for determining the SBP and DBP based on the appearance and disappearance of Korotkoff sounds, respectively. Two readings for SBP and DBP were taken and their average value was used in the analysis. Anthropometric measurements were measured using a soft flexible measuring tape. WC was measured in centimeters at the midpoint between the lowest rib and the highest point of the iliac crest. NC was measured at the level of the lower part of thyroid cartilage (just below Adam's apple) along a horizontal line in centimeters, with readings up to 1 decimal place.

Data analysis procedure

Data were entered on REDCap software (RedCap v9.1.0, Vanderbilt University) and analyzed using SPSS version 24.0 (IBM Corp, Armonk, NY). All the quantitative variables such as age, SBP and DBP, and biochemical parameters were assessed for normality and reported as mean ± SD or median (interquartile range \[IQR\]) as appropriate. The categorical variables were reported as frequencies and percentages. The prevalence of MetS was calculated using the criteria. Pearson or Kendall Tau-b correlation were used as appropriate to assess the relationship between NC and components of MetS. *P*-value \<0.05 was considered significant.

Results
=======

A total of 392 patients were included in the study, and the majority of patients 344 (87.8%)were females. The mean ± SD age and NC of all the patients were 50.5 ± 9.6 years and 38 ± 4.6 cm, respectively (Table [1](#TAB1){ref-type="table"}).

###### Characteristics of the study participants

IHD, ischemic heart disease

  ---------------------------------------------------- ------------
                                                       n (%)
  Gender                                               
  Male                                                 48 (12.2)
  Female                                               344 (87.8)
  Total                                                392 (100)
  Ethnicity                                            
  Sindhi                                               26 (6.6)
  Balochi                                              8 (2)
  Urdu speaking                                        185 (47.2)
  Punjabi                                              72 (18.4)
  Pathan                                               35 (8.9)
  Others                                               66 (16.8)
  Total                                                392 (100)
  Occupation                                           
  Professional                                         11 (2.8)
  Technicians and associate professionals              1 (0.3)
  Clerical support workers                             8 (2)
  Service and sales workers                            3 (0.8)
  Skilled agricultural, forestry and fishery workers   2 (0.5)
  Craft and related  trades workers                    3 (0.8)
  Housewife                                            303 (77.3)
  Others                                               61 (15.6)
  Total                                                392 (100)
  Comorbids                                            
  Hypertensive                                         309 (84.4)
  IHD                                                  31 (8.5)
  Dyslipidemia                                         224 (61.2)
  Diabetes                                             300 (82)
  Others                                               135 (36.9)
  Metabolic syndrome                                   
  Non-metabolic syndrome                               12 (3.1)
  Metabolic syndrome                                   366 (93.4)
  Unknown                                              14 (3.6)
  ---------------------------------------------------- ------------

More than three-quarters of the patients (n = 303; 77.3%) were homemakers, while 89 (22.7%) patients were doing any kind of job. Furthermore, comorbidities were present in all the patients. The most common comorbidity was hypertension (n = 309; 84.4%) followed by diabetes (n = 300; 82%) and dyslipidemia (n = 224; 61.2%).

Moreover, results showed that 366 (93.4%) of the patients has MetS, 12 (3.1%) were non-MetS, and 14 (3.6%) had unknown status due to incomplete information about the components of MetS (Table [2](#TAB2){ref-type="table"}).

###### Characteristics of the study participants with and without metabolic syndrome

SD, standard deviation; IQR, interquartile range; IHD, ischemic heart disease, HDL, high-density lipoprotein; HbA1c, glycated hemoglobin

  ------------------------------------------------------------------------------------------------------------- ---------------------------------------- ---------------------- ---------------------- --------------
  Characteristics                                                                                                                   Metabolic syndrome   Overall                P-value                
  No (n = 7)                                                                                                    Yes (n = 375)                                                                          
  Age (in years)                                                                                                                                                                                       
  Mean ± SD                                                                                                     47.2 ± 13.5                              50.5 ± 9.5             50.5 ± 9.6             0.749^ⱡ^
  Min-Max                                                                                                       30 to 60                                 24 to 79               24 to 79               
  Median (IQR)                                                                                                  55.5 (33 to 60)                          50 (45 to 56)          50 (45 to 56)          
  Height (cm)                                                                                                                                                                                          
  Mean ± SD                                                                                                     156.7 ± 7                                154 ± 7.9              154.1 ± 7.9            0.249^ⱡ^
  Min-Max                                                                                                       145 to 167.6                             103 to 180             103 to 180             
  Median (IQR)                                                                                                  157.5 (152.5 to 160)                     153 (149.5 to 158)     153 (150 to 158.8)     
  Weight (kg)                                                                                                                                                                                          
  Mean ± SD                                                                                                     78.8 ± 13.7                              77.5 ± 13.4            77.6 ± 13.5            0.571^ⱡ^
  Min-Max                                                                                                       60.4 to 95                               50 to 130              50 to 130              
  Median (IQR)                                                                                                  80 (61.5 to 91)                          75 (68 to 84)          75 (68 to 84.9)        
  BMI                                                                                                                                                                                                  
  Mean ± SD                                                                                                     32 ± 4.6                                 32.7 ± 5.7             32.8 ± 5.7             0.946^ⱡ^
  Min-Max                                                                                                       25.1 to 37.6                             23.2 to 75.4           23.2 to 75.4           
  Median (IQR)                                                                                                  33.1 (28.5 to 36.7)                      31.9 (29.1 to 35.2)    31.9 (29.1 to 35.3)    
  Waist circumference (cm)                                                                                                                                                                             
  Mean ± SD                                                                                                     39.8 ± 4.5                               43 ± 7                 43.2 ± 7.7             0.080^ⱡ^
  Min-Max                                                                                                       36 to 47                                 32 to 142              32 to 142              
  Median (IQR)                                                                                                  38.8 (36 to 45)                          42.3 (40 to 45)        42.2 (40 to 45)        
  Neck circumference (cm)                                                                                                                                                                              
  Mean ± SD                                                                                                     37.2 ± 2.8                               37.9 ± 3.9             38 ± 4.6               0.667^ⱡ^
  Min-Max                                                                                                       33 to 40.6                               29 to 78.7             29 to 88.9             
  Median (IQR)                                                                                                  36.8 (35.6 to 40.6)                      38.1 (35.6 to 40.6)    38.1 (35.6 to 40.6)    
  Systolic blood pressure (mm of Hg)                                                                                                                                                                   
  Mean ± SD                                                                                                     115.3 ± 9.6                              129.6 ± 16.6           129.3 ± 16.5           0.009^\*ⱡ^
  Min-Max                                                                                                       100 to 130                               90 to 190              90 to 190              
  Median (IQR)                                                                                                  117 (110 to 120)                         130 (120 to 140)       130 (120 to 140)       
  Diastolic blood pressure (mm of Hg)                                                                                                                                                                  
  Mean ± SD                                                                                                     71.4 ± 3.8                               78.8 ± 10.8            78.6 ± 10.7            0.038^\*ⱡ^
  Min-Max                                                                                                       70 to 80                                 60 to 110              60 to 110              
  Median (IQR)                                                                                                  70 (70 to 70)                            80 (70 to 90)          80 (70 to 90)          
  Fasting blood glucose                                                                                                                                                                                
  Mean ± SD                                                                                                     96.9 ± 15.7                              147.8 ± 61.3           145.8 ± 61             0.001^\*ⱡ^
  Min-Max                                                                                                       87 to 130                                43 to 438              43 to 438              
  Median (IQR)                                                                                                  90 (87 to 104)                           132 (108 to 167.3)     129.5 (106 to 165.5)   
  Total cholestrol                                                                                                                                                                                     
  Mean ± SD                                                                                                     185.4 ± 36.7                             167.3 ± 44.1           167.8 ± 43.6           0.281^†^
  Min-Max                                                                                                       129 to 226                               53 to 314.1            53 to 314.1            
  Median (IQR)                                                                                                  197 (138.7 to 206)                       166 (135 to 196)       166.2 (136 to 197)     
  Triglyceride                                                                                                                                                                                         
  Mean ± SD                                                                                                     90.3 ± 28.4                              167.7 ± 81.1           164.9 ± 80.8           0.001^\*ⱡ^
  Min-Max                                                                                                       65 to 135                                27 to 604.7            27 to 604.7            
  Median (IQR)                                                                                                  80 (65 to 118)                           150 (116.3 to 195.8)   147 (115 to 193.5)     
  HDL                                                                                                                                                                                                  
  Mean ± SD                                                                                                     55 ± 11.7                                38.5 ± 9.7             39.1 ± 10.3            0.001^\*ⱡ^
  Min-Max                                                                                                       41 to 69.8                               14 to 91               14 to 91               
  Median (IQR)                                                                                                  57 (42.3 to 69)                          37.1 (32 to 43.5)      38 (32.5 to 44)        
  LDL                                                                                                                                                                                                  
  Mean ± SD                                                                                                     119.3 ± 35.5                             110.1 ± 38.6           110.3 ± 38.2           0.398^ⱡ^
  Min-Max                                                                                                       63 to 157                                25 to 228              25 - 228               
  Median (IQR)                                                                                                  128 (78.6 - 151)                         105 (81 to 137.7)      106 (81.2 to 137)      
  VLDL-Cholesterol                                                                                                                                                                                     
  Mean ± SD                                                                                                     18 ± 5.8                                 34 ± 18.5              33.4 ± 18.4            0.001^\*ⱡ^
  Min-Max                                                                                                       13 to 27                                 5 to 206               5 to 206               
  Median (IQR)                                                                                                  16 (13 to 24)                            30 (23 to 39.3)        29 (23 to 39)          
  Non-HDL Cholesterol                                                                                                                                                                                  
  Mean ± SD                                                                                                     130.4 ± 40                               129.1 ± 42.2           128.8 ± 41.9           0.736^ⱡ^
  Min-Max                                                                                                       69 to 169                                35 to 273              35 to 273              
  Median (IQR)                                                                                                  140 (80 to 162)                          127 (97 to 155.3)      127.5 (97 to 155.2)    
  HbA1c                                                                                                                                                                                                
  Mean ± SD                                                                                                     5.4 ± 0.6                                8 ± 2                  7.9 ± 2                0.000^\*\*ⱡ^
  Min-Max                                                                                                       4.6 to 6.3                               4.1 to 14.9            4.1 to 14.9            
  Median (IQR)                                                                                                  5.4 (4.8 to 6)                           7.5 (6.4 to 9.2)       7.5 (6.3 to 9.1)       
  Comorbid                                                                                                                                                                                             
  Hypertensive                                                                                                  2 (28.6)                                 316(84.3)^a^           324 (82.7)             0.000^\*\*ɫ^
  IHD                                                                                                           0(0)                                     32 (8.5)               33 (8.4)               
  Dyslipidemia                                                                                                  6 (85.7)                                 224(60.3)              233 (59.4)             
  Diabetes                                                                                                      1 (14.3)                                 303(80.8)^a^           304 (77.6)             
  Others                                                                                                        5 (71.4)                                 141(37.6)              154 (39.3)             
  \*P-value\<0.05, \*\*P-value\<0.0001, † Independent Sample T-test, ⱡ Mann-Whitney U test, ɫ Chi-square test                                                                                          
  ------------------------------------------------------------------------------------------------------------- ---------------------------------------- ---------------------- ---------------------- --------------

It was observed that 90% of both males and females had NC ≥ 38 cm and 34 cm, respectively, and the optimal cutoff values were provided by Hingorjo MR et al. \[[@REF16]\]. Also, females had lower NC than males (mean ± SD: 37.5 ± 3.7 cm vs 41.4 ± 3.2 cm, p \< 0.0001).

Additionally, no significant linear correlation was between NC and HbA1C, total cholesterol, LDL, non-HDL cholesterol, fasting blood glucose levels, and SBP and DBP. A significant weak positive correlation was observed between NC and WC, VLDL cholesterol, and TG; however, a significant weak negative correlation was observed between NC and female gender and HDL (Table [3](#TAB3){ref-type="table"}).

###### Correlation of neck circumference with various variables

BMI, body mass index; TG, triglyceride; HDL, high-density lipoprotein; VLDL, very low density lipoprotein; LDL, low-density lipoprotein

  ----------------------------------------------------------------- ------------------------------------ ------------- ----------------------------------
                                                                    Unadjusted correlation coefficient   P-value       Adjusted correlation coefficient
  Females                                                           -0.329                               0.000^\*\*^   \-
  BMI                                                               0.184                                0.000^\*\*^   0.201\*\*
  Waist circumference in cm                                         0.290                                0.000^\*\*^   0.293\*\*
  TG                                                                0.107                                0.020^\*^     0.112
  HDL                                                               -0.123                               0.008^\*^     -0.087
  VLDL cholesterol                                                  0.106                                0.023^\*^     0.109
  HBA_RESULT                                                        0.069                                0.138         0.088
  Total cholesterol                                                 -0.068                               0.140         -0.051
  LDL                                                               -0.069                               0.134         -0.058
  Non-HDL cholesterol                                               -0.039                               0.394         -0.030
  Fasting blood glucose                                             0.037                                0.422         0.059
  Systolic (mm of Hg)                                               0.019                                0.695         0.011
  Diastolic (mm of Hg)                                              0.002                                0.966         -0.012
  \*P-value\<0.05, \*\*P-value\<0.0001, Kendall Tau-b correlation                                                      
  ----------------------------------------------------------------- ------------------------------------ ------------- ----------------------------------

On the contrary, NC was found to be significantly positively correlated with BMI and WC only adjusting for gender (Table [3](#TAB3){ref-type="table"}).

Discussion
==========

The National Nutrition Health Survey (2018) of Pakistan reported a high prevalence of overweight and obesity in adolescents, young adults, and women of reproductive age \[[@REF19]\]. Moreover, the prevalence of MetS has increased two folds over the last 10 years in Pakistan, indicating that these two are the emerging public health issues in Pakistan that require urgent attention of healthcare providers to restrain their increasing incidence \[[@REF7]-[@REF8]\]. Although Pakistan is facing an epidemic of obesity and MetS, no recent literature is available assessing the burden of MetS in general as well as in the overweight and obese population.

In this study, we found a very high prevalence of MetS (95.7%) in our overweight and obese patients in comparison to the previous studies done in Pakistan \[[@REF5],[@REF7]-[@REF8],[@REF20]\]. Also, in our study, the majority of patients were diabetic and hypertensive, which is one of the diagnostic components of MetS. Ahmed A et al. (2012) reported 91.9% prevalence of MetS in type 2 diabetic patients, whereas other studies reported a high prevalence of overweight and obesity among MetS patients \[[@REF5],[@REF7],[@REF19]\]. Moreover, a wide variation in the prevalence of MetS has been reported in various developing countries, i.e., from 7.9% to 39% \[[@REF21]\]. This enormous heterogeneity in the prevalence could be due to the different criteria used for MetS, ethnic variations, genetics, environmental and cultural differences, study settings, and other risk factors. Also, patients presenting to the Indus Hospital belong to low- and middle socioeconomic groups that could account for the high prevalence of MetS. Literature reports an association between low socioeconomic status (SES) and MetS as people belonging to low SES are less educated, have low healthcare knowledge, and less leisure-time physical activity and may be unemployed \[[@REF22]-[@REF23]\].

Furthermore, our study revealed that more than 90% of our study participants had NC greater than or equal to the optimal cut-off values provided by Hingorjo MR et al. \[[@REF17]\]. Thus, this indicates that these cut-off values can be used to screen MetS in the Pakistani population, thereby reducing the diagnostic testing. Several studies have reported the use of NC for identifying obesity and MetS by various criteria in different populations \[[@REF10],[@REF15],[@REF18],[@REF24]-[@REF25]\].

Additionally, we found a significant positive association between NC and VLDL and TG. This result is also supported by a recent systematic review and meta-analysis \[[@REF16]\]. Some of the components of MetS in our study were not significantly correlated with NC, which include HbA1c, SBP and DBP, TC, LDL, non-HDL, and fasting glucose levels, whereas Bochaliya et al., Cho et al., Ben-Noun, and Ataie Jafari showed significant association of these aforementioned variables with NC \[[@REF23],[@REF26]-[@REF28]\]. It was also shown by Ravikiran et al. that the risk of cardiovascular diseases and MetS among South Asians increased due to an increase in fat mass of intra-abdomen, body, and truncal subcutaneous and ectopic deposition, such as the region of the neck \[[@REF29]\]. In our study, BMI and WC were significantly associated with NC. The significant association between NC and BMI and WC was observed in other studies as well, which identified NC as an efficient tool for the identification of patients with obesity and MetS \[[@REF10],[@REF30]\]. Therefore, our study is in agreement with other studies that suggest NC as a good predictor of obesity and MetS.

Limitations

Since this study was a cross-sectional study, we could not establish an association between MetS and NC. We suggest either a longitudinal or a case-control study to establish any relationship between MetS and NC. Secondly, this is a single-center, hospital-based study with the majority of patients being females. Thirdly, in this study, we have included all the overweight and obese patients, out of which almost two-thirds were both diabetic and hypertensive, which are the components contributing to MetS due to which we found a very high prevalence of MetS. We recommend further community-based studies to assess the burden of the disease.

Conclusions
===========

A very high prevalence of MetS was observed among overweight and obese patients in this study. Moreover, NC can be used as a screening tool for MetS.
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